The Role of Gut Microbiota in Neurodegenerative Diseases: Current Insights and Therapeutic Implications

被引:11
|
作者
Jain, Arpit [1 ]
Madkan, Suryansh [2 ]
Patil, Praful [3 ]
机构
[1] Datta Meghe Inst Higher Educ & Res, Jawaharlal Nehru Med Coll, Anat, Wardha, India
[2] Maharishi Markandeshwar Univ, Ophthalmol, Ambala, India
[3] Datta Meghe Inst Higher Educ & Res, Jawaharlal Nehru Med Coll, Microbiol, Wardha, India
关键词
amytrophic lateral sclerosis; dysbiosis; gut microbiota; alzheimer's disease; parkinson' s disease; BRAIN; BOWEL; AXIS;
D O I
10.7759/cureus.47861
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Small microscopic entities known as microbes, having a population of hundreds of billions or perhaps even in trillions, reside in our gastrointestinal tract. A healthy immune system, digestion, and creation of vitamins and enzymes are all thanks to these microbes. However, new research has shown a hitherto unrecognized connection between the microbiota of the intestines and the genesis of neurodegenerative diseases. Neurons in the CNS gradually deteriorate in neurodegenerative illnesses like multiple sclerosis and Parkinson's disease (PD). This deterioration impairs cognitive and physical function. Amyotrophic lateral sclerosis (ALS), PD, and Alzheimer's disease (AD) are just a few examples of neurodegenerative illnesses that pose a serious threat to world health and have few effective treatments. Recent research suggests that the gut microbiota, a diverse microbial population found in the gastrointestinal system, may substantially impact the cause and development of various diseases. The discovery of altered gut microbiota composition in people with these illnesses is one of the most critical lines of evidence connecting gut microbiota dysbiosis to neurodegenerative diseases. AD patients have a distinct characteristic of having a particular microbiota profile. In addition, an excess population of a specific microbe data profile is seen as compared to a healthy individual. Similar changes in the gut microbiota composition have been noted in people with multiple sclerosis and PD. The latest study indicates the potential that dysbiosis, a condition characterized by alteration in the intestinal microbiotas makeup and functioning, may have an effect on the onset and progression of neurodegenerative diseases, including PD and multiple sclerosis. In order to emphasize any potential underlying mechanisms and examine potential treatment repercussions, the review article's goal is to summarize current knowledge about the connection between gut microbiota and neurodegenerative disorders. The review article aims to summarize current knowledge about the connection between gut microbiota and neurodegenerative disorders, highlighting potential underlying mechanisms and examining potential treatment repercussions.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Exosomes as Biomarkers and Therapeutic Agents in Neurodegenerative Diseases: Current Insights and Future Directions
    Dehghani, Sam
    Ocakci, Ozgecan
    Hatipoglu, Pars Tan
    Ozalp, Veli Cengiz
    Tevlek, Atakan
    MOLECULAR NEUROBIOLOGY, 2025,
  • [42] Microbiota-Gut-Brain Axis in Age-Related Neurodegenerative Diseases
    Nie, Tong
    You, Li
    Tang, Fang
    Duan, Yanhui
    Nepovimova, Eugenie
    Kuca, Kamil
    Wu, Qinghua
    Wei, Wei
    CURRENT NEUROPHARMACOLOGY, 2025, 23 (05) : 524 - 546
  • [43] Influence of the Gut Microbiota on the Development of Neurodegenerative Diseases
    Singh, Mahendra P.
    Chakrabarty, Riya
    Shabir, Shabnam
    Yousuf, Sumaira
    Obaid, Ahmad A.
    Moustafa, Mahmoud
    Al-Shehri, Mohammed
    Al-Emam, Ahmed
    Alamri, Abdulhakeem S.
    Alsanie, Walaa F.
    Alhomrani, Majid
    Shkodina, Anastasiia D.
    Singh, Sandeep K.
    MEDIATORS OF INFLAMMATION, 2022, 2022
  • [44] The Role of Fecal Microbiota Transplantation in the Treatment of Neurodegenerative Diseases: A Review
    Matheson, Julie-Anne T.
    Holsinger, R. M. Damian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (02)
  • [45] Mechanistic and Therapeutic Insights into Flavonoid-Based Inhibition of Acetylcholinesterase: Implications for Neurodegenerative Diseases
    Cichon, Natalia
    Grabowska, Weronika
    Gorniak, Leslaw
    Stela, Maksymilian
    Harmata, Piotr
    Ceremuga, Michal
    Bijak, Michal
    NUTRIENTS, 2025, 17 (01)
  • [46] Modifying the diet and gut microbiota to prevent and manage neurodegenerative diseases
    Gates, Ellen J.
    Bernath, Anna K.
    Klegeris, Andis
    REVIEWS IN THE NEUROSCIENCES, 2022, 33 (07) : 767 - 787
  • [47] Elucidating the role of gut microbiota dysbiosis in hyperuricemia and gout: Insights and therapeutic strategies
    Singh, Abhay Kumar
    Durairajan, Siva Sundara Kumar
    Iyaswamy, Ashok
    Williams, Leonard L.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (40)
  • [48] Gut Microbial Metabolome and Dysbiosis in Neurodegenerative Diseases: Psychobiotics and Fecal Microbiota Transplantation as a Therapeutic Approach-A Comprehensive Narrative Review
    Uceda, Sara
    Echeverry-Alzate, Victor
    Reiriz-Rojas, Manuel
    Martinez-Miguel, Esther
    Perez-Curiel, Ana
    Gomez-Senent, Silvia
    Beltran-Velasco, Ana Isabel
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
  • [49] The Role of Gut Microbiota in Aging and Aging Related Neurodegenerative Disorders: Insights from Drosophila Model
    Kong, Yan
    Wang, Liyuan
    Jiang, Baichun
    LIFE-BASEL, 2021, 11 (08):
  • [50] AMPK in Neurodegenerative Diseases: Implications and Therapeutic Perspectives
    Marinangeli, Claudia
    Didier, Sebastien
    Vingtdeux, Valerie
    CURRENT DRUG TARGETS, 2016, 17 (08) : 890 - 907